ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 39 filers reported holding ENANTA PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $2,524,000 | +25.9% | 75,357 | 0.0% | 0.02% | +38.9% |
Q3 2016 | $2,005,000 | +20.6% | 75,357 | 0.0% | 0.02% | +5.9% |
Q2 2016 | $1,662,000 | -24.9% | 75,357 | 0.0% | 0.02% | -26.1% |
Q1 2016 | $2,213,000 | -11.1% | 75,357 | 0.0% | 0.02% | +9.5% |
Q4 2015 | $2,488,000 | -8.6% | 75,357 | 0.0% | 0.02% | -16.0% |
Q3 2015 | $2,723,000 | -19.7% | 75,357 | 0.0% | 0.02% | -16.7% |
Q2 2015 | $3,390,000 | +46.9% | 75,357 | 0.0% | 0.03% | +57.9% |
Q1 2015 | $2,307,000 | -39.8% | 75,357 | 0.0% | 0.02% | -51.3% |
Q4 2014 | $3,832,000 | +28.5% | 75,357 | 0.0% | 0.04% | +2.6% |
Q3 2014 | $2,982,000 | -8.1% | 75,357 | 0.0% | 0.04% | -5.0% |
Q2 2014 | $3,246,000 | +0.3% | 75,357 | -6.9% | 0.04% | -2.4% |
Q1 2014 | $3,237,000 | +8.8% | 80,957 | -25.8% | 0.04% | -2.4% |
Q4 2013 | $2,976,000 | +3.9% | 109,097 | -12.7% | 0.04% | +2.4% |
Q3 2013 | $2,865,000 | +29.4% | 125,000 | 0.0% | 0.04% | -6.8% |
Q2 2013 | $2,214,000 | – | 125,000 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Krensavage Asset Management, LLC | 862,848 | $42,556,000 | 14.73% |
Fairmount Funds Management LLC | 171,147 | $8,441,000 | 3.56% |
ARMISTICE CAPITAL, LLC | 1,648,000 | $81,279,000 | 1.87% |
FARALLON CAPITAL MANAGEMENT LLC | 1,995,000 | $98,393,000 | 0.49% |
Jackson Creek Investment Advisors LLC | 21,409 | $1,056,000 | 0.37% |
Hennion & Walsh Asset Management, Inc. | 113,940 | $5,620,000 | 0.34% |
Virtus ETF Advisers LLC | 14,721 | $726,000 | 0.31% |
Granahan Investment Management | 193,416 | $9,539,000 | 0.20% |
Yorktown Management & Research Co Inc | 4,500 | $222,000 | 0.18% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 242,257 | $11,948,000 | 0.09% |